Vera Therapeutics, Inc. (VERA)
Vera Therapeutics, Inc. (VERA) is a Healthcare stock tracked by StreetAlpha. VERA reports earnings on Wed, Nov 4, 2026. Analyst consensus is Buy, based on the latest ratings from 4 firms (2 buy, 2 hold, 0 sell). Over the past 90 days StreetAlpha recorded 5 whale options trades in VERA, 80% of them bullish and 20% bearish. In the past 30 days there were 3 dark pool prints.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Oct 12 | Leerink Partners | Initiated | Hold | — |
| Sep 8 | JP Morgan | Maintained | Buy | — |
| Aug 12 | HC Wainwright & Co. | Target lowered | Buy | — |
| Aug 11 | Wedbush | Target lowered | Hold | — |
| Jul 8 | TD Cowen | Maintained | Buy | — |
Whale Options Flow
90DDark Pool
30DAI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether VERA is in one of them and how their past VERA trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered VERA in an article yet. Here's the latest on the wider market.